As South Korea enters a super-aged society, prostate cancer has risen to become the second most common cancer among men.

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

To address the challenge, Sino Biological has developed anti-whitlow 218 linker rabbit monoclonal antibodies, which specifically binds to the whitlow 218 linker sequence (GSTSGSGKPGSGEGSTKG). The ...

A research team led by Prof. HAN Shuo from the Center for Excellence in Molecular Cell Science of the Chinese Academy of Sciences developed a novel cell-surface protein engineering strategy called ...

CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors.

Tumor immunotherapies, especially those leveraging T-cells to identify and eliminate cancer cells, represent a major ...

Flu season is right around the corner in San Diego, and many people are searching for quicker, easier ways to find out if they’re sick.

Scientists in the laboratory of Weiguo Cui, Ph.D., professor of Pathology in the Division of Experimental Pathology, have ...

Moving Away From Standard Induction in Newly Diagnosed Acute Myeloid Leukemia As of April 2025, four CD19-directed chimeric antigen receptor (CAR)-T therapies and three CD20-targeting bispecific ...

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...